PTC Therapeutics Inc (NAS:PTCT)
$ 72.65 -1.06 (-1.44%) Market Cap: 6.06 Bil Enterprise Value: 4.53 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 62/100

PTC Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 20, 2026 / 02:00PM GMT
Release Date Price: $71.02 (+1.01%)
Brian Abrahams
RBC Capital Markets Inc - Managing Director

With RBC Capital Markets. Our next company is PTC Therapeutics, represented by their CEO, Matt Klein, and their CFO, Pierre Gravier.

Matt and Pierre, thanks so much for being here. Good to see you, Brian.

Thank you. Good to see you guys.

Questions & Answers

Brian Abrahams
RBC Capital Markets Inc - Managing Director

So let's get started. I wanted to first start with the launch of Cephiance.

Launch has obviously been going really well for you guys.

Can you talk a little bit about what specifically has been driving the strength of the recent launch, maybe the patterns of prescribing that you guys are seeing in the real world, where are the prescriptions coming from, how are you looking to potentially expand beyond kind of the initial centers of excellence? And then we'll kind of build off that. Yeah, absolutely.

Matthew Klein
PTC Therapeutics Inc - Chief Executive Officer, Director

Look, we are incredibly

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot